Top Clinical Trials companies in United States by Shares (Diluted, Weighted)

This ranking features the top 250 Clinical Trials companies in United States ranked by Shares (Diluted, Weighted), averaging a Shares (Diluted, Weighted) of 60,693,511, for January 15, 2025.

United States

Clinical Trials

#	Name	Shares (Diluted, Weighted)	Reported Date	Stock Price	Change	Country
1	ImmunityBio, Inc. 1 IBRX	682,149,430	Sept. 30, 2024	USD 2.32	-6.45%	United States
2	Geron Corporation 2 GERN	628,633,528	Sept. 30, 2024	USD 2.94	-1.34%	United States
3	Summit Therapeutics Inc. 3 SMMT	496,170,061	Sept. 30, 2023	USD 16.65	-8.42%	United States
4	Exelixis, Inc. 4 EXEL	301,001,250	Sept. 27, 2024	USD 35.65	0.99%	United States
5	PureTech Health plc 5 PRTC.L	276,302,533	Dec. 31, 2023	USD 1.72	1.09%	United States
6	Vertex Pharmaceuticals Incorporated 6 VRTX	260,274,999	Sept. 30, 2024	USD 411.66	-0.41%	United States
7	Nuvation Bio Inc. 7 NUVB	239,086,000	Sept. 30, 2024	USD 2.59	-3.00%	United States
8	Incyte Corporation 8 INCY	216,839,250	Sept. 30, 2024	USD 71.93	-0.61%	United States
9	Erasca, Inc. 9 ERAS	200,521,348	Sept. 30, 2024	USD 1.93	-10.23%	United States
10	Sangamo Therapeutics, Inc. 10 SGMO	194,058,000	Sept. 30, 2024	USD 1.02	-5.56%	United States
11	Savara Inc. 11 SVRA	189,206,338	Sept. 30, 2024	USD 2.72	-2.51%	United States
12	Allogene Therapeutics, Inc. 12 ALLO	184,169,844	Sept. 30, 2024	USD 1.92	-1.54%	United States
13	Legend Biotech Corporation 13 LEGN	182,076,812	June 30, 2024	USD 31.64	-2.65%	United States
14	Arbutus Biopharma Corporation 14 ABUS	180,274,978	Sept. 30, 2024	USD 3.18	-5.08%	United States
15	Lineage Cell Therapeutics, Inc. 15 LCTX.TA	172,663,000	Dec. 31, 2023	USD 0.59	-1.25%	United States
16	Revolution Medicines, Inc. 16 RVMD	159,474,756	Sept. 30, 2024	USD 39.83	-6.44%	United States
17	Neumora Therapeutics, Inc. Common Stock 17 NMRA	158,833,250	Sept. 30, 2024	USD 2.28	-5.79%	United States
18	TG Therapeutics, Inc. 18 TGTX	152,359,941	Sept. 30, 2024	USD 29.74	7.48%	United States
19	Adaptive Biotechnologies Corporation 19 ADPT	146,404,672	Sept. 30, 2024	USD 6.07	-6.04%	United States
20	Immunovant, Inc. 20 IMVT	145,608,325	Sept. 30, 2024	USD 22.88	0.57%	United States
21	Xeris Biopharma Holdings, Inc. 21 XERS	143,994,539	Sept. 30, 2024	USD 3.20	-2.44%	United States
22	Denali Therapeutics Inc. 22 DNLI	136,994,274	Sept. 30, 2023	USD 18.74	-4.34%	United States
23	Compass Therapeutics, Inc. 23 CMPX	134,863,500	Sept. 30, 2024	USD 2.00	2.56%	United States
24	Alnylam Pharmaceuticals, Inc. 24 ALNY	126,768,500	Sept. 30, 2024	USD 240.51	-6.88%	United States
25	NeoGenomics, Inc. 25 NEO	126,349,500	Sept. 30, 2024	USD 13.78	9.11%	United States
26	Mersana Therapeutics, Inc. 26 MRSN	121,800,336	Sept. 30, 2024	USD 0.63	2.01%	United States
27	Relay Therapeutics, Inc. 27 RLAY	121,549,928	Sept. 30, 2023	USD 4.35	-9.00%	United States
28	Guardant Health, Inc. 28 GH	121,429,500	Sept. 30, 2024	USD 37.46	-1.68%	United States
29	Annexon, Inc. 29 ANNX	117,739,281	Sept. 30, 2024	USD 4.53	-8.30%	United States
30	Biodesix, Inc. 30 BDSX	115,738,750	Sept. 30, 2024	USD 1.15	-7.26%	United States
31	Arrowhead Pharmaceuticals, Inc. 31 ARWR	115,552,750	June 30, 2024	USD 18.05	-4.55%	United States
32	Corcept Therapeutics Incorporated 32 CORT	111,442,000	Sept. 30, 2024	USD 51.66	1.18%	United States
33	Fate Therapeutics, Inc. 33 FATE	108,738,839	Sept. 30, 2024	USD 1.25	-3.10%	United States
34	Cytokinetics, Incorporated 34 CYTK	106,979,000	Sept. 30, 2024	USD 45.23	-3.17%	United States
35	Viking Therapeutics, Inc. 35 VKTX	106,217,911	Sept. 30, 2024	USD 33.93	-12.73%	United States
36	TScan Therapeutics, Inc. 36 TCRX	105,459,336	Sept. 30, 2024	USD 2.63	-3.31%	United States
37	Neurocrine Biosciences, Inc. 37 NBIX	103,525,000	Sept. 30, 2024	USD 139.51	-2.46%	United States
38	Intra-Cellular Therapies, Inc. 38 ITCI	100,663,056	Sept. 30, 2024	USD 126.89	-0.24%	United States
39	Trevi Therapeutics, Inc. 39 TRVI	100,271,557	Sept. 30, 2024	USD 3.93	-1.50%	United States
40	Sarepta Therapeutics, Inc. 40 SRPT	99,943,500	Sept. 30, 2024	USD 118.83	0.34%	United States
41	Acelyrin, Inc. 41 SLRN	98,623,770	Sept. 30, 2024	USD 2.10	-2.33%	United States
42	Avidity Biosciences, Inc. 42 RNA	98,391,750	Sept. 30, 2024	USD 27.05	-4.79%	United States
43	89bio, Inc. 43 ETNB	95,862,417	Sept. 30, 2024	USD 6.28	-0.47%	United States
44	Poseida Therapeutics, Inc. 44 PSTX	95,347,411	Sept. 30, 2024	USD 9.50	NA	United States
45	Alector, Inc. 45 ALEC	92,886,042	Sept. 30, 2024	USD 1.64	-8.38%	United States
46	Caribou Biosciences, Inc. 46 CRBU	89,633,168	Sept. 30, 2024	USD 1.56	0.65%	United States
47	Day One Biopharmaceuticals, Inc. 47 DAWN	89,491,370	Sept. 30, 2024	USD 11.16	-3.46%	United States
48	Allakos Inc. 48 ALLK	88,319,250	Sept. 30, 2024	USD 0.88	1.92%	United States
49	Intellia Therapeutics, Inc. 49 NTLA	86,456,250	Sept. 30, 2023	USD 9.74	-3.08%	United States
50	Immunic, Inc. 50 IMUX	86,119,466	Sept. 30, 2024	USD 1.00	-6.54%	United States

1 2 3 4 5

Frequently Asked Questions

Which Clinical Trials company in United States has the highest Shares (Diluted, Weighted) ?

The Clinical Trials company in United States with the highest Shares (Diluted, Weighted) is ImmunityBio, Inc. (NasdaqGS: IBRX) at 682,149,430.
Which Clinical Trials company in United States has the lowest Shares (Diluted, Weighted) ?

The Clinical Trials company in United States with the lowest Shares (Diluted, Weighted) is Cingulate Inc. (NasdaqCM: CING) at 56,333.

What are the top 10 Clinical Trials companies in United States by Shares (Diluted, Weighted) ?

The top 10 Clinical Trials companies in United States by Shares (Diluted, Weighted) are ImmunityBio, Inc., Geron Corporation, Summit Therapeutics Inc., Exelixis, Inc., PureTech Health plc, Vertex Pharmaceuticals Incorporated, Nuvation Bio Inc., Incyte Corporation, Erasca, Inc. and Sangamo Therapeutics, Inc..
What are the bottom 10 Clinical Trials companies in United States by Shares (Diluted, Weighted) ?

The bottom 10 Clinical Trials companies in United States by Shares (Diluted, Weighted) are Cingulate Inc., Palisade Bio, Inc., Allarity Therapeutics, Inc., Phio Pharmaceuticals Corp., 180 Life Sciences Corp., Theriva Biologics, Inc., Tharimmune, Inc., Cadrenal Therapeutics, Inc. Common Stock, Cyclacel Pharmaceuticals, Inc. and Salarius Pharmaceuticals, Inc..